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3T3-L1Lipid rafts are plasma membrane microdomains that are highly enriched with cholesterol and sphingolipids
and in which various receptors and other proteins involved in signal transduction reside. In the present work,
we analyzed the effect of cholesterol biosynthesis inhibition on lipid raft/caveolae composition and
functionality and assessed whether sterol precursors of cholesterol could substitute for cholesterol in lipid
rafts/caveolae. 3T3-L1 preadipocytes were treated with distal inhibitors of cholesterol biosynthesis or vehicle
(control) and then membrane rafts were isolated by sucrose density gradient centrifugation. Inhibition of
cholesterol biosynthesis with either SKF 104976, AY 9944, 5,22-cholestadien-3β-ol or triparanol, which
inhibit different enzymes on the pathway, led to a marked reduction in cholesterol content and accumulation
of different sterol intermediates in both lipid rafts and non-raft domains. These changes in sterol composition
were accompanied by disruption of lipid rafts, with redistribution of caveolin-1 and Fyn, impairment of
insulin-Akt signaling and the inhibition of insulin-stimulated glucose transport. Cholesterol repletion
abrogated the effects of cholesterol biosynthesis inhibitors, reﬂecting they were speciﬁc. Our results show
that cholesterol is required for functional raft-dependent insulin signaling.© 2009 Elsevier B.V. All rights reserved.1. IntroductionCholesterol is an essential molecule in animals, serving as a
principal component of plasma membranes, an obligatory precursor
for the biosynthesis of steroid hormones, bile acids, and bioactive
oxysterols, and also exerting regulatory functions. Cholesterol bio-
synthesis involves successive enzymatic reactions that ﬁrst convert
acetyl-CoA into the 30-carbon molecule squalene, then cycle that
molecule to yield the ﬁrst sterol, lanosterol, and ﬁnally, through
additional 18 enzymatic reactions including 3 demethylations and
double-bond reorganizations, generate cholesterol (Fig. 1).
Lipid rafts are plasma membrane microdomains that are highly
enriched with cholesterol and sphingolipids [1]. Caveolae are
considered as a subtype of lipid raft that are formed in cells expressing
caveolin [2]. Lipid rafts/caveolae have been shown to be involved in
endocytosis/transcytosis, cholesterol transport, tumorigenesis, and
regulation of signal transduction [2–5].estigación, Hospital Ramón y
el.: +34 91336 8077; fax: +34
ll rights reserved.Various signaling molecules and receptors are recruited into
caveolae by caveolins through their scaffolding domain [6]. Bringing
these signaling molecules into close proximity enables efﬁcient signal
transduction [7]. The insulin receptor (IR) and many molecules
involved in the IR signaling cascade have been shown to concentrate
in caveolin-enriched plasma membrane domains from adipocytes [8–
10], a ﬁnding that could not be conﬁrmed in other studies [11].
Caveolin-1 is phosphorylated by the IR [10] and functions as an
activator of IR signaling [12]. In fact, both caveolin-1-deﬁcient mice
and caveolin-3 knockout mice suffer from insulin resistance [13,14].
Very recently, the cavin-knockout mouse, which lacks morphologi-
cally detectable caveolae andmarkedly diminished protein expression
of the three caveolin isoforms, has been reported to have glucose
intolerance and hyperinsulinemia [15], all of which underscore the
role of caveolae in insulin action.
Cholesterol appears to be essential for the stability and function-
ality of lipid rafts/caveolae. Inhibition of 3-hydroxy-3-methylglutaryl-
CoA-reductase (HMG-CoA reductase) by statins [16,17] or membrane
cholesterol depletion using methyl-cyclodextrin [8,18,19] resulted in
lipid raft disruption, modiﬁcation of lipid raft composition, and
inhibition of cell signaling. Likewise, RNA interference-mediated
inhibition of squalene synthase affected several cell functions by
selectively reducing the cholesterol content of lipid rafts [20].
Fig. 1. Scheme of the cholesterol biosynthesis pathway showing the enzymes inhibited by SKF 104976, AY 9944, 5,22-cholestadien-3β-ol, and triparanol.
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membranes is well described [21] but their distribution into lipid
raft and non-raft areas of the membrane and their role in caveolae
function are not well understood. Their properties in stabilizing rafts
have been studied in membrane models. 7-Dehydrocholesterol
(7DHC) promotes liquid-ordered domain formation more strongly
than cholesterol [22], but has a markedly different effect on
membrane organization and dynamics [23]. However, more proximal
sterol intermediates stabilize raft formation weakly [24]. Lateral
pressure, which plays a signiﬁcant role in the activation of membrane
proteins, is altered when cholesterol is replaced by either desmosterol
or 7DHC [25].
In rats treatedwith AY9944, aΔ7-reductase inhibitor, 7DHChas been
shown to incorporate into lipid rafts as efﬁciently as cholesterol but the
raft protein content was perturbed [26]. Desmosterol may replace
cholesterol in the formation of unilamellar vesicles with phospholipids
[27]; however, in mammalian cell membranes, exchanging cholesterol
for desmosterol leads to impaired raft-dependent signaling [28,29].
Likewise, desmosterol-reductase-deﬁcient ﬁbroblasts, which accumu-
late desmosterol in membranes instead of cholesterol, have disrupted
caveolae and impaired insulin-Akt-Bad signaling [7].
In the present work, to study the effects of cholesterol deprivation
and to explore whether sterol precursors could substitute for
cholesterol in lipid rafts/caveolae, we treated 3T3-L1 preadipocytes
with different inhibitors acting on the conversion of lanosterol into
cholesterol. The results show that inhibition of cholesterol biosynth-
esis causes marked reductions in cholesterol content and accumula-
tion of sterol intermediates in both raft and non-raft membrane
domains. This is accompanied by disruption of lipid rafts/caveolae,
redistribution of caveolin-1, and impairment of insulin signaling. The
results of our study demonstrate the stringency of the sterol
requirement of lipid rafts/caveolae for insulin receptor activation in
3T3-L1 preadipocytes.2. Materials and methods
All chemicals, unless otherwise stated, were purchased from Sigma
(Sigma-Aldrich Química, S.A., Tres Cantos, Madrid, Spain).2.1. Culture of 3T3-L1 cells
3T3-L1 preadipocyte cells (ATCC CL-173) (Rockville, MD, USA)
were cultured in DMEM supplemented with 10% fetal bovine serum
(FBS) and antibiotics (Gibco BRL, Invitrogen S.A., Prat de Llobregat,
Barcelona, Spain) at 37 °C in a 5% CO2 atmosphere. For experiments,
cells were cultured in DMEM with 10% lipoprotein-deﬁcient serum
(LPDS) and treated with the drugs for 24 h. LPDS was prepared from
FBS by ultracentrifugation at a density of 1.21 kg/L. Sterols
(cholesterol and 5,22-cholestadien-3β-ol, [Steraloids Inc., Newport,
RI, USA]) were dissolved in ethanol; cholesterol biosynthesis
inhibitors (SKF 104976 [GlaxoSmithKline plc., Brentford, Middlesex,
United Kingdom], AY 9944 [Wyeth-Ayerst Research, Wyeth Madison,
NJ, USA], and triparanol [Sigma]) were dissolved in DMSO. The ﬁnal
concentrations of DMSO and ethanol in the mediumwere 0.044% and
0.44%, respectively.
The following inhibitors of cholesterol biosynthesis were used at
the indicated doses: 3 μM SKF 104976 (an inhibitor of lanosterol 14α-
demethylase), 5 μM AY 9944 (an inhibitor of 3β-hydroxysterol Δ7-
reductase), 1 μg/mL 5,22-cholestadien-3β-ol (an inhibitor of sterol
Δ24 reductase), and 3 μM triparanol (an inhibitor of sterol Δ24
reductase, as well as β-hydroxysterol Δ7-reductase, Δ8,7-isomerase,
and sterol Δ14-reductase, depending on the dose). The effect of these
compounds on cholesterol biosynthesis enzymes has been reported
elsewhere [30–32]. The doses used were selected to achieve maximal
inhibition of 14C-acetate incorporation into cholesterol (Supplemental
results and Supplementary Fig. 1).
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Mitochondrial activity was analyzed with the MTT assay (cell
proliferation kit I (MTT); Boehringer-Mannheim [Barcelona, Spain]) in
3T3-L1 cells treated with or without cholesterol biosynthesis
inhibitors (3 μM SKF 104976, 5 μM AY 9944, 1 μg/mL 5,22-
cholestadien-3β-ol and 3 μM triparanol) during 24 h. The MTT assay
determines the ability of cells tometabolize 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT). At the end of the cell
treatment period, 300 μL of culture medium were removed from a
total of 500 μL of each well and 20 μL of MTT solution (5 mg/mL) were
added and incubated for 2 h. At this time, 200 μL of solubilization
solution (10% SDS in HCl 0.01M)was then added to thewells and after
overnight incubation at 37 °C, 100 μL was transferred into 96-well
microtiter plate, and the absorption value at 550 nmwas measured in
an automatic microtiter reader (Spectra Fluor, Tecan).
2.3. Immunoﬂuorescence microscopy
3T3-L1 cells were cultured on glass coverslips, ﬁxed with 4%
paraformaldehyde/PBS for 5 min. Next, cells were permeabilized in
0.1% triton X-100/PBS for 5 min and blocked with 2% bovine serum
albumin (BSA) in PBS for 45 min. Free cholesterol was stained with
ﬁlipin (50 mg/L in PBS) for 45 min; caveolin-1 with anti-caveolin-1
(1:100, 2 h) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and
Alexa ﬂuor 488-conjugated anti-rabbit IgG (Molecular Probes,
Invitrogen S.A.); and nuclei with 1 μM TO-PRO-3 (Molecular Probes)
for 15 min. For GM1 staining, the cells were incubated with cholera
toxin B-FITC (CtxB-FITC) (1:100) (Sigma) for 30 min before ﬁxing.
Cells were examined on an Olympus BX51 (Olympus España, S.A.,
Barcelona, Spain) reﬂected ﬂuorescence microscope for ﬁlipin and
caveolin or a Bio-Rad (Bio-Rad Laboratories S.A., El Prat de Llobregat,
Barcelona, Spain) laser confocal ﬂuorescence microscope for GM1 and
caveolin. Images of ﬁlipin staining were pseudocolored in red.
2.4. Sucrose gradient fractionation of membranes
To separate membrane fractions we used a modiﬁed version of a
previously described detergent-free method [33]. 3T3-L1 cells (175-
mm ﬂask) were scraped into 2 mL of 500 mM sodium carbonate, pH
11, sonicated 2 bursts of 30 s each and centrifuged for 30 min at
14,000 g to obtain a Golgi-free supernatant. Then Golgi-free super-
natant proteins were measured by bicinchoninic acid (BCA) protein
assay (Pierce Biotechnology, Inc., Rockford, IL, USA). Equal amounts of
membrane proteins were then adjusted to 42.5% sucrose by the
addition of 2 mL of 85% sucrose prepared in MBS (25 mMMes, pH 6.5,
0.15 M NaCl) and placed at the bottom of an ultracentrifuge tube. A
5%–35% discontinuous sucrose gradient was formed above (2mL of 5%
sucrose, 5 mL of 30% sucrose, 1 mL of 35% sucrose) and centrifuged at
39,000 rpm for 18–20 h in an SW41 rotor (Beckman Instruments, Palo
Alto, CA, USA). Twelve 1-mL fractions were collected from the top of
the gradient and processed for caveolin-1 and anti-transferrin
receptor (TfR) (Zymed, Invitrogen S.A.) analysis by Western blot. For
phosphotyrosine residues, insulin receptor [IR], and Fyn (Santa Cruz
Biotechnology), the fractions were concentrated by 10% trichloroace-
tic acid precipitation prior to electrophoretic analysis. Fraction
proteins were measured using the BCA protein assay.
2.5. Insulin stimulation
3T3-L1 cells were cultured in medium containing 10% LPDS
(control) and treated with cholesterol biosynthesis inhibitors alone
or in combination with free cholesterol (30 μg/mL). Cells were serum
starved for 2–4 h before insulin stimulation, which was performed in
serum-free medium supplemented with 20 nM insulin (Sigma) for
10 min. Then, membranes were fractionated as mentioned before andequal volumes from gradient fractions were analyzed byWestern blot.
To study insulin-dependent Akt phosphorylation, cells were serum
starved for 6 h, stimulated with 100 nM insulin for 20 min and
collected for preparation of whole-cell lysates by using lysis buffer
containing 50 mM Tris–HCl pH 7.5, 125 mM NaCl, 1% Nonidet P40,
5mMNaF,1.4mMNaP pyro,1mMNa3VO4, and protease inhibitor, and
used for subsequent Western blot.
2.6. Western blotting
Equal volumes of each gradient fraction or whole-cell lysates
(50 μg) were subjected to 8%–12% SDS-PAGE and transferred to
nitrocelullose membranes (Amersham Biosciences, Piscataway, NJ,
USA). After blocking, blots were probed with speciﬁc antibodies.
Horseradish peroxidase-conjugated secondary antibodies (Santa Cruz
Biotechnology) were used and bands were visualized using a
chemiluminescence detection system (VersaDoc, Bio-Rad). Phospho-
Akt-S473 and Akt antibodies were obtained from Cell Signaling
Technology Inc. (Danvers, MA, USA) and GADPH from Santa Cruz
Biotechnology. To study IR phosphorylation, membranes were blotted
ﬁrstly with an antibody which recognizes phosphotyrosine residues
(p-Tyr) (Santa Cruz Biotechnology) and, after stripping, with an
antibody against the insulin receptor [IR] β subunit (Santa Cruz
Biotechnology).
2.7. Glucose uptake measurement
Prior to the assay, 3T3-L1 preadipocytes were serum deprived for
2 h in DMEM containing 0.2% BSA. Cells were incubated in the
presence or absence of insulin (100 nM) at 37 °C for 30 min. The
transport assay was initiated by the addition of 2-deoxy-D-glucose
(1 mM ﬁnal concentration), containing 0.5 mCi of 2-deoxy-D-[3H]
glucose (Amersham, GE Healthcare España, S.A., Barcelona, Spain) in
Krebs–Ringer–Hepes buffer and incubated for 10 min at 37 °C. Then,
the cells were washed 3 times in ice-cold 50 mM D-glucose in PBS.
Background activity was determined by measuring the transport in a
solution that contained 50 mM D-glucose. Cells were lysed with ice-
cold 0.1 N NaOH-0.1% SDS and aliquots were taken for determination
of [3H] radioactivity. d.p.m. value was corrected by protein content in
each well which was measured using a BCA protein assay kit.
2.8. Analysis of sterols by HPLC
3T3-L1 cells (175-mm ﬂask) were incubated in 10% LPDS medium
for 24 h in the absence (control) or presence of the different drugs.
Sterols were extracted from either the whole-cell lysates or the
fractions of the sucrose gradient and analyzed by reversed-phase
HPLC, as described previously [30]. The eluted sterols were identiﬁed
by comparison of the retention time and the ultraviolet spectrum
against those of pure standards.
2.9. Analysis of sterol biosynthesis by HPLC
The 3T3-L1 cells were preincubated for 2 h in the absence (control)
or presence of cholesterol biosynthesis inhibitors. The medium was
then supplemented with 40 μCi of [14C]-acetate and incubation was
prolonged 8 h further. At the end of the incubation, the cells were
washed with PBS and resuspended in 10% (w/v) KOH. Then, the non-
saponiﬁable lipids were extracted and used for sterol separation by
reversed-phase HPLC, as described [31]. The eluent was monitored
simultaneously by UV-absorption spectroscopy (Diodo Array 168
detector, Beckman Coulter España, S.A.) and online radioactivity
counting (Radioﬂow detector LB 509, Berthold Technologies GmbH &
Co. KG, Bad Wildbad, Germany).
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Extracted sterols were analyzed as described before [34]. Brieﬂy,
sterols extracted were dissolved into tert-butylmethylether (TBME)
and derivatized with silylation reagent (N-methyl-N-trimethylsily-
triﬂuoroacetamide/Trimethylsilylimidazole 9:1). The column used
was a Varian EZ Guard Factor Four 5MS 30 m×0.25 mm×0.25 μm
(+10 m methyl deactivated guard column). The MS operated in full
scan mode at 40 μamp emission current and a scan time of 0.4 s.
2.11. Analysis of phospholipids by TLC
Lipids were extracted from the fractions of the sucrose gradient
with chloroform-methanol (2:1), and phospholipids were quantiﬁed
following an image analysis after separation by one-dimensional thin
layer chromatography [35] using the GS-800 BIOIMAGE thin layer
chromatography scanner (Bio-Rad). Optical density of the spots was
compared to standards on each plate and curves were drawn from
second-order least-square regression equations on the standards.
2.12. Statistical analysis
Data were presented as mean±SD. Statistical analyses were
performed using a two-tailed, paired Student's t-test. The difference
between 2 sets of values was considered signiﬁcant when the P value
was b0.05.
3. Results
3.1. Changes in sterol composition of plasma membrane domains by
effect of different cholesterol biosynthesis inhibitors
To study the effects of cholesterol starvation on lipid rafts/
caveolae, we incubated 3T3-L1 cells in a cholesterol-deﬁcient
medium and treated them with selected enzyme inhibitors at
optimal doses for maximal inhibition of cholesterol biosynthesis. As
expected, the cellular cholesterol content decreased after a 24 h
treatment with each inhibitor (Supplementary Table 1); this ﬁnding
is interpreted as the result of both cholesterol biosynthesis inhibition
and cell division [31]. Treatment of cells with the cholesterol
biosynthesis inhibitors for 24 h had no appreciable effects on cell
proliferation as measured by the MTT assay (Supplementary Fig. 2).
Treatment with these inhibitors also resulted in the accumulation of
substrates of the inhibited enzymes (Supplementary Table 1). Thus,
3 μM SKF 104976 led to accumulation of lanosterol and dihydrola-
nosterol, consistent with inhibition of lanosterol 14α-demethylase
[31,36]. Treatment with 5 μM AY 9944 resulted in the accumulation ofTable 1
Effects of different cholesterol biosynthesis inhibitors on the sterol content of plasma mem
Treatment Cholesterol Lanosterol Dihydrolanosterol
Raft Non-raft Raft Non-raft Raft Non-raft
Control 508±118 42.9±24.2 – – – –
Cholesterol 699±222 73.1±38.5 – – – –
SKF 104976 302±46⁎ 27.0±5.7 27.9±0.3 3.9±0.5 158.0±17.3 9.5±1.4
SKF 104976+
cholesterol
529±146 58.3±30.1 17.5±6.6 3.2±1.1 51.2±1.7 12.4±6.2
AY 9944 333±78⁎ 28.2±8.9 – – – –
AY 9944+
cholesterol
671±190⁎⁎ 39.8±17.0 – – – –
5,22-cholestadien-
3β-ol
257±34⁎ 17.3±5.4 – – – –
Triparanol 180±19⁎ 12.6±2.1 – – – –
3T3-L1 cells were left untreated (control) or treated for 24 hwith 30 μg/mL free cholesterol a
cholestadien-3β-ol, or 3 μM Triparanol. Lipids were extracted from each fraction and sterols
protein (raft, fractions 2+3; non-raft, fractions 8+9+10) (n=3, mean±S.D.). Compariso
7DHC, 7-dehydrocholesterol; 7DHD, 7-dehydrodesmosterol; –, not detectable.7DHC and 7-dehydrodesmosterol (7DHD), consistent with the
inhibition of 3β-hydroxysterol Δ7-reductase [31]. 5,22-Cholesta-
dien-3β-ol (1 μg/mL) treatment led to accumulation of desmosterol
and 7DHD, indicating the inhibition of Δ24-reductase [30], and 3 μM
triparanol resulted in the accumulation of 7DHD, zymosterol, and
cholesta-8(9),14,24-trien-3β-ol, as conﬁrmed by GC/MS analysis
(Supplementary Fig. 3), indicating a strong inhibition of Δ24-
reductase [32] as well as inhibition of Δ7-reductase, Δ8,7-isomerase,
and Δ14-reductase, in that order.
We next analyzed the composition of the different plasma
membrane fractions. Contamination from Golgi membranes was
almost completely eliminated, as assessed by β-COP immunoblotting
(data not shown). Protein content in lighter fractions was very low
and it sharply increased from fraction 7 to forth, fraction 9 usually
having values 40 times higher than those in fractions 2 or 3 (data not
shown). As regard to the lipid composition, fractions 2 and 3 were
enriched in cholesterol as compared to any of the other single
fractions, as these two fractions contain approximately 43% of the total
cholesterolmass in the 12membrane fractions (Supplementary Table 2).
Paralleling cholesterol, fractions 2 and 3 were also enriched in
sphingomyelin, by contrast, the phosphatidylcholine content was
much higher in fractions 8 to 10 than in the others (Supplementary
Table 2). These results are in line with those previously reported by
others indifferent cell types [37,38], and indicate that lipid rafts/caveolae
were separated in fractions 2 and 3. For the description of the results
from thedifferent experiments, data from fractions 2 and3, representing
lipid rafts/caveolae and, separately, data from fractions 8, 9, and 10,
representative of the non-raft domain, were summed up (Table 1). In
control cells, cholesterol content in lipid rafts was much greater
(approximately 12 times) than in the non-raft fraction (Table 1).
Expressed as a percentage, fractions 2 and 3 represented 40.7±7.7% and
fractions 8–10, 29.7±6.6% of the cholesterol present in the membrane
preparation. Incubation of cells with free cholesterol increased choles-
terol content in both fractions to a similar extent (Table 1). Treatment
with any cholesterol biosynthesis inhibitor notably decreased the
cholesterol content in raft and non-raft domains (Table 1). Concomi-
tantly, sterol precursors were incorporated into these membrane
fractions. Thus, inhibition of Δ24-reductase with 5,22-cholestadien-3β-
ol resulted in the appearance of desmosterol and 7DHD in both
membrane fractions, while zymosterol and 7DHD were detected in
triparanol-treated cells (Table 1). In cells treated with SKF 104976,
simultaneous supplementation with cholesterol prevented the reduc-
tion of cholesterol levels in membrane domains but did not impede
the incorporation of substantial amounts of lanosterol and dihydro-
lanosterol into raft and non-raft fractions (Table 1). Similarly, in cells
treated with AY 9944, supplementing the medium with cholesterol
prevented the reduction in membrane cholesterol but only reduced inbrane fractions.
7DHC 7DHD Desmosterol Zymosterol
Raft Non-raft Raft Non-raft Raft Non-raft Raft Non-raft
– – – – – – – –
– – – – – – – –
– – – – – – – –
– – – – – – – –
68.2±1.0 2.6±2.1 24.6±1.2 2.7±1.8 – – – –
42.0±2.8 1.6±1.4 11.0±1.1 – – – – –
– – 79.2±18.8 7.7±6.2 26.0±3.5 2.0±1.0 – –
– – 30.3±2.5 2.9±1.1 – – 41.0±4.0 3.5±1.4
nd/or cholesterol biosynthesis inhibitors: 3 μMSKF 104976, 5 μMAY 9944,1 μg/mL 5,22-
were analyzed by HPLC. Data are shown as μg of each sterol species per mg of fraction
ns vs. Control: ⁎Pb0.05; comparison of AY 9944+Cholesterol vs. AY 9944: ⁎⁎Pb0.05.
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To explore whether the inhibition of cholesterol biosynthesis
affects the polar lipid composition of raft and non-raft membrane
fractions, additional experiments were performed and both sterols
and phospholipids were analyzed and the results are given as
Supplementary material. In general, in contrast to the sterol
composition (Supplementary Table 3) treatment with the different
cholesterol biosynthesis inhibitors barely affected the content of
phospholipids and their distribution in any raft and non-raft
fractions (Supplementary Table 4). Of interest, the total sterol/
sphingomyelin molar ratio in the raft fraction was found to be
approximately 2.6 in control cells, compared to 2.5, 3.1, 2.8 and 2.4
in cells treated with SKF 104976, AY 9944, 5,22-cholestadien-3β-ol
and triparanol, respectively. A subtle change in the proportions of
phosphatidylinositol (increase) and phosphatidylserine (decrease)
in raft fractions was observed by effect of the cholesterol
biosynthesis inhibitors but the signiﬁcance of this effect is elusive
and further studies will be required to elucidate its biological
relevance.
3.2. Colocalization of cholesterol and caveolin-1 with GM1 in the
plasma membrane
Immunocytochemical studies conﬁrmed that cholesterol, as
detected by ﬁlipin staining, colocalized with GM1 in membranes from
3T3-L1 cells (Fig. 2A). Treatment with any cholesterol biosynthesisFig. 2. Colocalization of cholesterol or caveolin-1 with GM1 in 3T3-L1 cells. Untreated cells (
cholestadien-3β-ol, or 3 μM triparanol are shown. A) Plasma membrane cholesterol was det
caveolin-1 (red) and GM1 (green). Magniﬁcation, ×400.inhibitor reduced the staining for both cholesterol and GM1 and their
colocalization on the cell surface, indicating decreased raft levels. To
visualize GM1 and caveolin-1 we used confocal laser scanning
microscopy (Fig. 2B). In untreated 3T3-L1 cells, GM1 colocalized with
caveolin-1 at the plasmamembrane. Inhibition of cholesterol biosynth-
esis resulted in a loss of both caveolin and GM1 staining at the cell
surface and, interestingly, they no longer colocalized (Fig. 2B),
conﬁrming the decrease in lipid rafts/caveolae as a result of cholesterol
starvation.
3.3. Cholesterol inhibition reduces caveolin-1 content in lipid
rafts/caveolae
In control cells, immunoreactive caveolin-1 wasmainly detected in
fractions 2 and 3, indicating that these fractions contain lipid rafts/
caveolae, whereas TfR, a marker of the non-raft membrane domain,
was only detected in fractions 8–11 (Fig. 3A). Inhibition of cholesterol
biosynthesis with SKF 104976 resulted in a marked decrease in
caveolin-1 content in fraction 2, while there was an increase in
caveolin-1 in non-raft fractions (Fig. 3B). Similar results were
obtained with the other inhibitors (Fig. 3C). Thus, inhibition of
cholesterol biosynthesis led to a shift in the distribution of caveolin-1
from lipid rafts/caveolae to denser membrane domains. Supplement-
ing the medium with free cholesterol prevented the effects of
cholesterol biosynthesis inhibitors (Fig. 3B and 3C). Taken together
with the immunocytochemical studies described above, these results
indicate that cholesterol starvation disrupts lipid rafts/caveolae.control) and cells treated for 24 h with 3 μM SKF 104976, 5 μM AY 9944, 1 μg/mL 5,22-
ected with ﬁlipin (red) and GM1 with CTxB-FITC (green). B) Immunocytochemistry for
Fig. 3. Inhibition of cholesterol synthesis reduces caveolin-1 content in the lipid raft/
caveolae fraction. A)Western blotting of gradient fractions with anti-caveolin-1 (Cav-1)
and anti-TfR antibodies. B) Western blot with anti-caveolin-1 in 3T3-L1 cells either
untreated (control) or treated with cholesterol alone (30 μg/mL), 3 μM SKF 104976
alone, or a combination of SKF 104976 and cholesterol. C) Densitometric analysis of
caveolin-1 Western blots. The caveolin-1 levels are expressed as a percentage of total
caveolin-1 (n=3, mean±SD). The representative results are shown in A and B.
Asterisks (⁎) Pb0.05 compared with control.
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signaling and insulin-stimulated glucose uptake
The IR is sequestered in caveolae microdomains of the plasma
membrane in adipocytes through an association with caveolin, and
evidence exists that caveolae are critical for insulin control [8–10]. In
3T3-L1 cells, we found that the IR β subunit was mainly detected in
light, lipid raft fractions, and a similar distribution was obtained for
Fyn, a Src tyrosine kinase involved in insulin signaling (Fig. 4A). To
examine the effect of cholesterol starvation on IR activation, 3T3-L1
cells were treatedwith the cholesterol biosynthesis inhibitors alone or
in combinationwith free cholesterol and then stimulated with insulin
for the last 10min. Cells not treated with inhibitors and not exposed to
insulinwere used as a control for IR activation. As shown in Fig. 4B and
C, IR levels did not change signiﬁcantly in response to inhibition of
cholesterol biosynthesis. Addition of insulin to the incubationmedium
resulted in the phosphorylation of the IR (Fig. 4B). This effect was
markedly lower in cells treated with cholesterol biosynthesis
inhibitors than in control (+insulin) cells. Coincubation with
cholesterol restored IR activation to control values (Fig. 4B and C).
Moreover, Fyn levels decreased in treated cells, an effect that was
prevented by adding cholesterol to the incubation medium (Fig. 4B).
In 3T3-L1 preadipocytes, it has been shown that insulin activates
phosphatidylinositol 3-kinase (PI3K)/Akt pathway, which is critical
for the regulation of adipocyte differentiation [39]. As shown in Fig.
4D, insulin increased the phosphorylation of Akt-S473 in control cells.
In contrast, Akt phosphorylation was markedly impaired in cells
treated with cholesterol biosynthesis inhibitors, demonstrating that
the coupling of IR with lipid rafts was functionally associated with
insulin signaling in 3T3-L1 cells. Coincubation with cholesterol
restored Akt phosphorylation to control values (Fig. 4D).
In certain cell types, insulin stimulates glucose transport. To
ascertainwhether cholesterol starvation affects insulin action, glucose
transport was measured. As shown in Fig. 5, insulin caused a
stimulation of glucose transport in 3T3-L1 preadipocytes, and all of
the cholesterol biosynthesis inhibitors, SKF 104976, AY 9944 and
triparanol, produced signiﬁcant inhibition of the ability of insulin to
enhance glucose uptake. The coincubation of the inhibitors with
cholesterol restored insulin-stimulated glucose transport to control
values. Just for comparison, in our system methyl β-cyclodextrin
practically abrogated insulin-stimulated glucose transport, which is in
accordance with previous results reported by others [8,18].
Taken together these results indicate that the lack of cholesterol
impairs IR activation and intracellular signaling and that cholesterol
precursors accumulating in cells treated with cholesterol biosynthesis
inhibitors cannot replace cholesterol in this function.
4. Discussion
This study focused on the effects of different distal inhibitors of
cholesterol biosynthesis on lipid raft/caveolae stability and signal
transduction in 3T3-L1 preadipocytes. Speciﬁcally, we examined
whether sterols formed during intermediate steps in cholesterol
biosynthesis could substitute for cholesterol in lipid raft/caveolae
formation, with the goal of deﬁning the role of different sterols in this
microdomain. For this purpose, compounds known to inhibit
lanosterol 14α-demethylase, Δ7-reductase, or Δ24-reductase were
tested [30–32,36]. The inhibition of cholesterol biosynthesis led to a
reduction of cholesterol content in the plasma membrane and an
accumulation of sterol precursors in lipid raft and non-raft domains;
this was accompanied by profound alteration of lipid raft/caveolae
architecture and functionality. Although sterol intermediates, espe-
cially 7DHC, were efﬁciently incorporated into lipid rafts and most
likely contributed to membrane stability, they did not fulﬁll the
requirements for correct protein accommodation into those signal
integration platforms. The provision of sufﬁcient cholesterol to cells
Fig. 4. Insulin receptor (IR) activation and lipid raft/caveolae association after inhibition of cholesterol biosynthesis. A) Western blotting for the IR β subunit and Fyn in gradient
fractions. B) Western blotting with anti-IR, anti-pTyr (as a marker of active receptors), and anti-Fyn antibodies in untreated (control) cells (a) or cells stimulated with insulin: control+
insulin (b) or treated for 24 hwith 3 μMSKF 104976 alone (c) or in combinationwith cholesterol (d). C)QuantiﬁcationofWestern blots for the IR and IR activation (pTyr) (n=3–4,mean±
SD). ⁎Pb0.05 comparedwith control+insulin. D)Whole-cell lysatesWestern blotting using anti-phospho-Akt (p-S473), anti-Akt (total) and anti-GADPH antibodies. Ins indicates insulin;
Chol, cholesterol; SKF, SKF 104976; AY, AY 9944; Trip, triparanol. Representative immunoblots are shown in A, B and D.
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strating the superiority of cholesterol over its immediate sterol
precursors in lipid raft/caveolae function.
The inhibition of HMG-CoA reductase with statins has been shown
to disrupt the distribution of signaling molecules within rafts,
resulting in alterations in cell signaling [16,17]. Nonetheless, the
inhibition of HMG-CoA reductase may compromise not only the
provision of cholesterol but also that of non-sterol mevalonate
derivatives important for cell physiology. It is currently unclear
whether those effects of statins are due to impairment of raft integrity
and the initial raft-dependent phosphorylation cascade or to
malfunction of small GTPases due to inhibition of protein prenylation
[40]. Therefore, to study the effects of cholesterol deprivation more
speciﬁcally, cholesterol biosynthesis was inhibited at more distal
points in the pathway. By using this approach, we herein showed, for
the ﬁrst time, that early sterol precursors in the cholesterol
biosynthetic pathway, such as, for example, lanosterol and dehydro-
lanosterol, are incorporated in substitution for cholesterol into lipid
rafts, where they likely contribute to sustaining the physical proper-
ties of membranes while being unable to participate in the formation
of functional caveolae.
Caveolin-1 containing rafts are sensitive to cholesterol depletion
[4]. Disruption of lipid rafts by the extraction of membrane cholesterol
with methyl-cyclodextrins has been shown to delocalize signaling
molecules and to inhibit raft-dependent signaling events [8,18,19,41].
Similarly, we found that treatment with different distal cholesterol
synthesis inhibitors resulted in a shift of caveolin-1 localization in
3T3-L1 cells. Other authors reported that substitution of cholesterol by
desmosterol in membranes decreases the afﬁnity of caveolin-1 for
sterol and perturbs caveolar morphology [29]. Likewise, desmosterol-
reductase-deﬁcient cells, which accumulate desmosterol instead ofcholesterol in their membranes, exhibit disrupted caveolae with
markedly reduced caveolin-1 content [7]. Taken together, the results
indicate that the accumulation of sterol intermediates does not
compensate for the decrease in cholesterol, which shows the super-
iority of cholesterol in maintaining caveolae integrity.
In addition, the results of the present study in 3T3-L1 preadipo-
cytes demonstrated that the IR is localized in caveolae puriﬁed using a
detergent-free method, a ﬁnding consistent with those of previous
studies in other cell types [8–10]. Insulin uses the PI3K-Akt pathway
for most of its metabolic actions, such as the stimulation of glucose
transport, glycogen synthesis, and lipogenesis [42]. PI3K inhibitors
block adipocyte differentiation [43], and the expression of a
constitutively active form of Akt is sufﬁcient to induce adipogenesis
[44]. These observations indicate that Akt represents a major PI3K
effector in the insulin signaling pathway [44].
Biophysical studies have provided compelling evidence of the
superiority of cholesterol over its sterol precursors [27,45]. In general,
the more structurally similar a precursor is to cholesterol, the greater
its capacity to maintain the biophysical properties of the membrane
and the arrangement of proteins functioning within. Thus, while
lanosterol, the sterol precursor most distant from cholesterol, leads to
poor packing in phospholipid artiﬁcial membranes, desmosterol
behaves very similarly to cholesterol in lipid packing [27]. 7DHC, the
last cholesterol precursor with a saturated side-chain, has been shown
to be an even stronger promoter of lipid raft domains than cholesterol
[22,24], which is consistent with our observation that 7DHC
preferentially localizes to raft fractions; its concentration was 27-
fold greater in raft than in non-raft domains, a concentration gradient
that is much steeper than found for any other sterol, including
cholesterol (Table 1). Nevertheless, recent studies have demonstrated
that replacement of cholesterol with either 7DHC or desmosterol
Fig. 5. Inhibition of glucose uptake by cholesterol biosynthesis inhibitors. 3T3-L1 cells
were incubated without (untreated) or with cholesterol synthesis inhibitors (3 μM SKF
104976, 5 μM AY 9944 and 3 μM triparanol) or in combination with cholesterol (30 μg/
ml) for 48 h, or 10 mM methyl-β-cyclodextrin (MCD) for 50 min, followed by
incubationwith 100 nM insulin for 30min and the uptake of 2-deoxy-D[3H]glucose was
determined over 5 min. Total uptake was calculated per mg protein in the cell extract
and these values were used to determine the percentage inhibition as compared to the
control (not stimulated by insulin) (n=4, mean±SD). Comparisons vs. untreated
⁎Pb0.05; comparison of inhibitors+cholesterol vs. inhibitor alone: †Pb0.05.
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property important to membrane processes as it affects the activation
of membrane proteins through changes in their conformational state
[46]. In line with this, our results showed that alteration of membrane
sterol composition by inhibition of cholesterol biosynthesis impairs
downstream propagation of the insulin signal, as indicated by
decreased phosphorylation of the IR and Akt, and uncoupling of Fyn
from caveolae. Notably, the inhibition of cholesterol biosynthesis
signiﬁcantly inhibited insulin-stimulated glucose uptake. Previous
studies by Stralfors' group reported that the extraction of membrane
cholesterol by cyclodextrin abrogates the ability of insulin to enhance
glucose transport [8,18], which was conﬁrmed in the present study.
Vainio et al. demonstrated that exchanging membrane cholesterol for
desmosterol leads to impaired insulin receptor activation [28].
Likewise, mouse embryonic ﬁbroblasts from DHCR24−/− mice,
which are unable to synthesize cholesterol and accumulate desmos-
terol in membranes, exhibit impaired insulin-dependent phosphor-
ylation of IRS-1, Akt, and Bad [7]. In addition, cells from AY 9944-
treated rats or cells deﬁcient in Δ7-reductase have been shown to
exhibit partially disrupted lipid rafts, in which Lyn kinase protein and
activity are displaced [47]. Whether this latter ﬁnding is a direct effect
of 7DHC, which is efﬁciently incorporated into these domains [26], or
is due to the presence of other, accompanying sterol precursors such
as 7DHD requires further investigation. In agreement with these
previous reports, we found that inhibition of Δ7-reductase in 3T3-L1
preadipocytes results in the dissociation of caveolin-1 and Fyn from
lipid rafts/caveolae and impairs IR autophosphorylation and insulin-
dependent Akt activation. Taken together these results indicated that
sterol precursors of cholesterol, while contributing to the basicbiophysical properties of membranes, are ineffective in providing
the necessary environment for protein functionality in lipid rafts/
caveolae, underscoring the structural speciﬁcity of cholesterol for IR
functionality. It has been proposed that cholesterol directly interacts
with the oxytocin receptor thereby stabilizing the receptor and
modulating its binding activity [48]. Whether cholesterol similarly
interacts with the IR has not been determined so far and a direct action
of cholesterol on IR functionality therefore cannot be ruled out.
The superiority of cholesterol over its biosynthetic precursors was
also demonstrated for other membrane receptors. It was recently
reported that ligand binding and signaling of the seronotin-1A receptor,
a G-protein-coupled receptor, are impaired in cells depleted of
cholesterol or treated with AY 9944, and the replenishment of
cholesterol but not 7DHC restores ligand binding to the receptor [49,50].
To thebest of ourknowledge, no studyaddressing theactionof insulin
in patients affected by congenital cholesterol biosynthesis defects has
been published so far. In DHCR7-deﬁcient mast cells, which accumulate
7DHC in lipid rafts and exhibit partially disrupted lipid rafts, Lyn kinase
protein is displaced from lipid rafts and the activity of the enzyme is
reduced [47]. Mouse embryonic ﬁbroblasts from DHCR24−/− mice
accumulate desmosterol inmembranes and also exhibit impaired insulin
signaling [7]. Regarding the effects of cholesterol biosynthesis inhibition,
NB598, an inhibitor of squalene epoxidase, was recently reported to
inhibit both basal and glucose-stimulated insulin secretion from mouse
pancreatic islets [51]. These effects were reversed by cholesterol, similar
to our results in 3T3-L1 cells. Whether dietary cholesterol is sufﬁcient to
abolish the potential alterations in insulin signaling in patients with
defective cholesterol biosynthesis is not known.
The requirement for cholesterol in other cell processes, such as cell
growth and division, has been recognized for many years. However, it
is still unclear whether this requirement simply reﬂects the role of
cholesterol as a membrane component or whether cholesterol also
plays a regulatory role in cell functions. Previous studies by our group
[52] and others [53] suggested that cholesterol exerts regulatory
actions with effects on cell cycle progression. The results of this study,
showing that cholesterol is required for efﬁcient signal processing in
rafts, suggest a link between membrane cholesterol and, more
generally, regulatory actions in the cell.
In conclusion, the present study provides evidence of a stringent
cholesterol requirement for lipid raft/caveolae stability and function-
ality. Sterol precursors in the cholesterol biosynthesis pathway do not
maintain the insulin signaling cascade inpreadipocytes. The possibility
exists that ﬁne tuning of the sterol composition in rafts by
physiological changes in the activity of enzymes involved in choles-
terol biosynthesis modulates the response to extracellular signals.
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